Back to Results
First PageMeta Content
Health / Drug development / Pre-clinical development / Food and Drug Administration / Therapeutic index / Good Laboratory Practice / Good manufacturing practice / Drug discovery / Adverse effect / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry


Overview of Drug Development: the Regulatory Process Roger D. Nolan, PhD Director, Project Operations Calvert Research Institute November, 2006
Add to Reading List

Open Document

File Size: 386,93 KB

Share Result on Facebook

Company

Test Population Laboratory / PhD / /

Country

Australia / /

Facility

Calvert Research Institute / University of Melbourne / Project Operations Calvert Research Institute / LaTrobe University / /

IndustryTerm

manufacturing practices / drug product / chemical structure / /

MedicalTreatment

folk medicine / /

Organization

GMP GLP GCP QC QA AWC EMEA HPB MHW ICH Organization / FDA / University of Melbourne / Center for Drug Evaluation and Research / Project Operations Calvert Research Institute / Center for Devices and Radiological Health / Calvert Research Institute / Center for Biologics Evaluation and Research / IND NDA / LaTrobe University / /

Person

Pharmacology / Biochemistry / Roger D. Nolan / /

Position

Assistant Professor / Scientist / Director / Director / Project Operations / /

Product

Cary The New Drug / /

Technology

Drug Development / rational drug design / /

URL

www.fda.gov / /

SocialTag